Cargando…

Reactive arthritis occurring after COVID-19 infection: a narrative review

PURPOSE: Reactive arthritis is acute aseptic arthritis occurring 1 to 4 weeks after a distant infection in a genetically predisposed individual. It may occur after COVID-19 infection. We summarize, in this article, the current findings of reactive arthritis following COVID-19 infection. METHODS: A l...

Descripción completa

Detalles Bibliográficos
Autores principales: Slouma, Maroua, Abbes, Maissa, Mehmli, Takoua, Dhahri, Rim, Metoui, Leila, Gharsallah, Imen, Louzir, Bassem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162104/
https://www.ncbi.nlm.nih.gov/pubmed/35655110
http://dx.doi.org/10.1007/s15010-022-01858-z
_version_ 1784719626929700864
author Slouma, Maroua
Abbes, Maissa
Mehmli, Takoua
Dhahri, Rim
Metoui, Leila
Gharsallah, Imen
Louzir, Bassem
author_facet Slouma, Maroua
Abbes, Maissa
Mehmli, Takoua
Dhahri, Rim
Metoui, Leila
Gharsallah, Imen
Louzir, Bassem
author_sort Slouma, Maroua
collection PubMed
description PURPOSE: Reactive arthritis is acute aseptic arthritis occurring 1 to 4 weeks after a distant infection in a genetically predisposed individual. It may occur after COVID-19 infection. We summarize, in this article, the current findings of reactive arthritis following COVID-19 infection. METHODS: A literature search has been performed from December 2019 to December 2021. We included case reports of reactive arthritis occurring after COVID-19 infection. We collected demographic, clinical, and paraclinical data. RESULTS: A total of 22 articles were reviewed. There were 14 men and 11 women with a mean age of 44.96 + 17.47 years. Oligoarticular involvement of the lower limbs was the most frequent clinical presentation. The time between arthritis and COVID infection ranged from 6 to 48 days. The diagnosis was based on clinical and laboratory findings. The pharmacological management was based on non-steroidal anti-inflammatory drugs in 20 cases. Systemic or local steroid therapy was indicated in 13 patients. Sulfasalazine was indicated in two cases. Alleviation of symptoms and recovery were noted in 22 cases. The mean duration of the clinical resolution was 16 + 57 days. CONCLUSION: The diagnosis of reactive arthritis should be considered in patients with a new onset of arthritis following COVID-19 infection. Its mechanism is still unclear.
format Online
Article
Text
id pubmed-9162104
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91621042022-06-02 Reactive arthritis occurring after COVID-19 infection: a narrative review Slouma, Maroua Abbes, Maissa Mehmli, Takoua Dhahri, Rim Metoui, Leila Gharsallah, Imen Louzir, Bassem Infection Review PURPOSE: Reactive arthritis is acute aseptic arthritis occurring 1 to 4 weeks after a distant infection in a genetically predisposed individual. It may occur after COVID-19 infection. We summarize, in this article, the current findings of reactive arthritis following COVID-19 infection. METHODS: A literature search has been performed from December 2019 to December 2021. We included case reports of reactive arthritis occurring after COVID-19 infection. We collected demographic, clinical, and paraclinical data. RESULTS: A total of 22 articles were reviewed. There were 14 men and 11 women with a mean age of 44.96 + 17.47 years. Oligoarticular involvement of the lower limbs was the most frequent clinical presentation. The time between arthritis and COVID infection ranged from 6 to 48 days. The diagnosis was based on clinical and laboratory findings. The pharmacological management was based on non-steroidal anti-inflammatory drugs in 20 cases. Systemic or local steroid therapy was indicated in 13 patients. Sulfasalazine was indicated in two cases. Alleviation of symptoms and recovery were noted in 22 cases. The mean duration of the clinical resolution was 16 + 57 days. CONCLUSION: The diagnosis of reactive arthritis should be considered in patients with a new onset of arthritis following COVID-19 infection. Its mechanism is still unclear. Springer Berlin Heidelberg 2022-06-02 2023 /pmc/articles/PMC9162104/ /pubmed/35655110 http://dx.doi.org/10.1007/s15010-022-01858-z Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Slouma, Maroua
Abbes, Maissa
Mehmli, Takoua
Dhahri, Rim
Metoui, Leila
Gharsallah, Imen
Louzir, Bassem
Reactive arthritis occurring after COVID-19 infection: a narrative review
title Reactive arthritis occurring after COVID-19 infection: a narrative review
title_full Reactive arthritis occurring after COVID-19 infection: a narrative review
title_fullStr Reactive arthritis occurring after COVID-19 infection: a narrative review
title_full_unstemmed Reactive arthritis occurring after COVID-19 infection: a narrative review
title_short Reactive arthritis occurring after COVID-19 infection: a narrative review
title_sort reactive arthritis occurring after covid-19 infection: a narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162104/
https://www.ncbi.nlm.nih.gov/pubmed/35655110
http://dx.doi.org/10.1007/s15010-022-01858-z
work_keys_str_mv AT sloumamaroua reactivearthritisoccurringaftercovid19infectionanarrativereview
AT abbesmaissa reactivearthritisoccurringaftercovid19infectionanarrativereview
AT mehmlitakoua reactivearthritisoccurringaftercovid19infectionanarrativereview
AT dhahririm reactivearthritisoccurringaftercovid19infectionanarrativereview
AT metouileila reactivearthritisoccurringaftercovid19infectionanarrativereview
AT gharsallahimen reactivearthritisoccurringaftercovid19infectionanarrativereview
AT louzirbassem reactivearthritisoccurringaftercovid19infectionanarrativereview